Aarti Pharmalabs Ltd.

The Total revenue for the quarter ended March 2023 of  Rs. 3742.70 millions remain, more or less, the same.The Net proft of the company remain more or less same to Rs. 400.00  millions from Rs. 448.80 millions ,decline by -10.87%.The company reported a good operating profit of 768.00 millions compared to 707.20 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202303	202203	% Var	202303	202203	% Var	202303	202203	% Var
Sales	3742.70	3647.00	2.62	15112.50	9410.20	60.60	15112.50	9410.20	60.60
Other Income	0.00	25.10	-100.00	12.80	25.10	-49.00	12.80	25.10	-49.00
PBIDT	768.00	707.20	8.60	3096.20	1822.90	69.85	3096.20	1822.90	69.85
Interest	58.00	44.00	31.82	204.90	113.40	80.69	204.90	113.40	80.69
PBDT	710.00	663.20	7.06	2891.30	1709.50	69.13	2891.30	1709.50	69.13
Depreciation	142.50	124.40	14.55	557.70	372.30	49.80	557.70	372.30	49.80
PBT	567.50	538.80	5.33	2333.60	1337.20	74.51	2333.60	1337.20	74.51
TAX	167.50	90.00	86.11	616.30	270.00	128.26	616.30	270.00	128.26
Deferred Tax	27.50	15.00	83.33	95.00	45.00	111.11	95.00	45.00	111.11
PAT	400.00	448.80	-10.87	1717.30	1067.20	60.92	1717.30	1067.20	60.92
Equity	453.10	455.60	-0.55	453.10	455.60	-0.55	453.10	455.60	-0.55
PBIDTM(%)	20.52	19.39	5.82	20.49	19.37	5.76	20.49	19.37	5.76